Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma
Year: 2025
Type: article
Language: en
Topic: Ovarian cancer diagnosis and treatment
Authors and affiliations:
raw_author_name: Robert L. Hollis
raw_affiliation_strings: 1The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom
University of Edinburgh 1 Edinburgh
raw_author_name: Austin Miller
raw_affiliation_strings: 2NRG Oncology, Clinical Trial Development Division, Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York
Roswell Park Cancer Institute 2 Buffalo, NY
raw_author_name: Heather A. Lankes
raw_affiliation_strings: 3NRG Oncology, Operations Center-Philadelphia East, Philadelphia, Pennsylvania
4Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, Ohio
NRG Oncology 3 Philadelphia, PA
raw_author_name: Kwong-Kwok Wong
raw_affiliation_strings: 5Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center 4 Houston, TX
raw_author_name: William Rodgers
raw_affiliation_strings: 6NYPQ, Department of Pathology, Weill Medical College of Cornell University, New York, New York
Weill Cornell Medicine 5 New York,
raw_author_name: David Millan
raw_affiliation_strings: 7Queen Elizabeth University Hospital, Glasgow, United Kingdom
Queen Elizabeth University Hospital 6
raw_author_name: Karen Carty
raw_affiliation_strings: 8Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom
Beatson West of Scotland Cancer Centre 7 Glasgow
raw_author_name: Robert L. Coleman
raw_affiliation_strings: 5Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
US Oncology Network 8 The Woodlands, TX
raw_author_name: Kathleen N. Moore
raw_affiliation_strings: 9Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, Oklahoma
University of Oklahoma Health Sciences Center Oklahoma City, OK United States
raw_author_name: Angeles Alvarez Secord
raw_affiliation_strings: 10Duke Cancer Institute, Durham, North Carolina
Duke Cancer Institute Durham, NC United States
raw_author_name: David M. O’Malley
raw_affiliation_strings: 11Ohio State University and the James Cancer Center, Columbus, Ohio
Ohio State University Hospital 11 Columbus, OH
raw_author_name: John K. Chan
raw_affiliation_strings: 12Gynecologic Oncology, Sutter Cancer Research Consortium, San Francisco, California
Sutter Cancer Research Consortium San Francisco, CA United States
raw_author_name: Andrea R. Hagemann
raw_affiliation_strings: 13Washington University, Gynecologic Oncology, St. Louis, Missouri
Washington University in St. Louis 13 St. Louis, Missouri
raw_author_name: Stephanie Gaillard
raw_affiliation_strings: 14Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, Maryland
Johns Hopkins Medicine 14 Baltimore, Maryland
raw_author_name: Saketh R. Guntupalli
raw_affiliation_strings: 15Gynecologic Oncology, University of Colorado School of Medicine, UC Health CU Cancer Center, Anschutz Medical Campus, Aurora, Colorado
University of Colorado Anschutz Medical Campus 15 Aurora, CO
raw_author_name: Mitchell I. Edelson
raw_affiliation_strings: 16Abington Hospital, Gynecologic Oncology, Abington, Pennsylvania
Abington Memorial Hospital 16 Willow Grove, PA
raw_author_name: Peter G. Rose
raw_affiliation_strings: 17Gynecologic Oncology, Case Comprehensive Cancer Center and Cleveland Clinic, Cleveland, Ohio
Cleveland Clinic Foundation Cleveland, OH United States
raw_author_name: Oliver Dorigo
raw_affiliation_strings: 18Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford Women’s Cancer Center, Stanford Cancer Institute, Stanford, California
Stanford University 18 Stanford, CA
raw_author_name: Susana Banerjee
raw_affiliation_strings: 19The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, United Kingdom
Royal Marsden NHS Foundation Trust 19 London, London
raw_author_name: Ailith Ewing
raw_affiliation_strings: 20MRC Human Genetics Unit & CRUK Scotland Centre, Institute of Genetics and Cancer, The University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom
University of Edinburgh 1 Edinburgh
raw_author_name: Michael Churchman
raw_affiliation_strings: 1The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom
University of Edinburgh 1 Edinburgh
raw_author_name: Anil K. Sood
raw_affiliation_strings: 5Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center 4 Houston, TX
raw_author_name: C. Simon Herrington
raw_affiliation_strings: 1The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom
University of Edinburgh 1 Edinburgh
raw_author_name: Charlie Gourley
raw_affiliation_strings: 1The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom
University of Edinburgh 20 Edinburgh, Midlothian
raw_author_name: David M. Gershenson
raw_affiliation_strings: 5Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center 4 Houston, TX